Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Strategy

Juno's progressive thinking

How Juno is assembling a tool kit for next-generation immunotherapies

June 8, 2015 7:00 AM UTC

Juno Therapeutics Inc. is doing exactly what investors in broad product platform companies want: raising significant amounts of money and using the dollars to build out a suite of tools to enable the next generation of products.

The cancer immunotherapy company has been clear from the outset that business development was in the cards...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article